In an unprecedented partnership for a better future, The Elie Wiesel Foundation for Humanity, The Galien Foundation and the Cura Foundation have launched bold debate and discussion focused on humanity’s bioethical road map.

Elie Wiesel and his wife, Marion, established The Elie Wiesel Foundation for Humanity soon after he was awarded the 1986 Nobel Prize for Peace. The Foundation’s mission, rooted in the memory of the Holocaust, is to combat indifference, intolerance and injustice through international dialogue and youth-focused programs that promote acceptance, understanding and equality.

The international conferences of The Elie Wiesel Foundation for Humanity serve as a catalyst for change and action. The conferences, which focus on themes of Peace, Education, Health, the Environment and Terrorism, serve to bring together Nobel Laureates and world leaders to discuss social problems and develop suggestions for change. The Foundation hosted its inaugural conference, Facing the 21st Century: Threats & Promises, in 1988 gathering 79 Nobel Laureates in Paris. The Conference paved the way for a series of conferences including: The Anatomy of HateTomorrow’s LeadersThe Future of Hope; and the Petra Conferences of Nobel Laureates.

In the United States, the Foundation has for 27 years offered the Ethics Essay Contest which challenges college juniors and seniors to analyze the urgent ethical issues confronting them in today’s complex world.

For more than 20 years, the Foundation operates two Beit Tzipora Centers for Study and Enrichment in Israel. These Centers, in Ashkelon and Kiryat Malachi, focus on educating the Ethiopian-Jewish community and giving Ethiopian-Israeli students the opportunity to participate fully in Israeli society. Close to one thousand boys and girls are currently enrolled in after-school programs that serve as a model for other schools.

The Galien Foundation fosters, recognizes, and rewards excellence in scientific innovation that improves the state of human health. The Foundation’s mission is to serve as a vehicle for the open exchange of ideas that drive science and new innovations and its vision is to catalyze the development of the next generation of innovative treatment and technologies that will improve health and save lives. 

The Foundation’s scope is global, and its commitment to progress in medicine is both measurable and concrete.  Members of the Foundation express this through the establishment of productive relationships to build lasting bridges between the commercial research enterprise and local communities engaged in public policy, science, finance, academic research and the media. 

The Galien Foundation is a non-profit 501(c)(3) foundation and it oversees and directs activities in the United States for the Prix Galien, an international award that recognizes outstanding achievements in improving the human condition through the development of innovative therapies.   Founded in France 45 years ago by pharmacist Roland Mehl in honor of Galen, the father of medical science and modern pharmacology, the Prix Galien supports, recognizes and awards the efforts of scientists, researchers and companies committed to advancing medical innovation with the power to change the human condition. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.

APF is a non-profit 501(c)(3) organization of North American healthcare professionals and others devoted to the advancement of medical leadership and excellence in Israel. Its mission is to support the health and wellbeing of the Israeli population by promoting innovation, high-quality training and expert medical care.

Through APF programs and grants, we build exponentially the critical bonds between Israeli and North American healthcare professionals, increasing the knowledge base needed for medicine in Israel to grow and thrive. To assist with these critical efforts, the APF engages supporters dedicated to the State of Israel, to Jewish learning, and to medical advancement, improving medical treatment, saving lives, and strengthening the leadership in the field of medicine.

Skip to content